Leap Therapeutics Inc (LPTX) – Strategy, SWOT and Corporate Finance Report
- Pages: 49
- Published: May 2023
- Report Code: MLPH2503744FSA
Leap Therapeutics Inc (LPTX) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Leap Therapeutics Inc (Leap Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with different types of cancer. The company’s pipeline products include DKN-01. DKN-1 is a monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, intended for the treatment of gastroesophageal cancer, prostate cancer and gynecologic cancer. FL-301, a monoclonal antibody that targets Claudin18.2, is being tested in patients with gastric and pancreatic cancer. The company has an agreement with BeiGene Ltd for development rights and commercialization of DKN-01 in Australia, Asia (excluding Japan) and New Zealand. Leap Therapeutics is headquartered in Cambridge, Massachusetts, the US.
Scope
• Detailed information on Leap Therapeutics Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Leap Therapeutics Inc in the form of a SWOT analysis
• An in-depth view of the business model of Leap Therapeutics Inc including a breakdown and examination of key business segments
• News about Leap Therapeutics Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Leap Therapeutics Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Leap Therapeutics Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Leap Therapeutics Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Bristol-Myers Squibb Co
Astellas Pharma Inc
Elevation Oncology Inc
Bristol-Myers Squibb Co
Novartis Corp
Pfizer Inc
Amgen Inc
BioCardia Inc
Transcenta Holding Ltd
Merck & Co Inc
Merck & Co Inc
Novartis Corp
Pfizer Inc
Amgen Inc
BioCardia Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.